YORK UNIVERSITY
DEPARTMENT OF POLITICAL POLS 6245.03 – The
Global Politics of
Health
Fall 2018
Seminar Time: Tuesday, 14:30-17:30
Seminar Location: South Ross 536
Instructor: Rodney Loeppky
Office Location: Ross S631
E-mail: rloeppky@yorku.ca
Office Hours: Wednesday 13:00-15:00
Telephone: 416-735-2100 x 30085
Course Description:
‘Health’ has emerged as an issue of global
politics,
cutting across disciplinary and national boundaries. It has become directly
relevant to the study
of international organizations, ‘globalisation’, domestic politics
and social
restructuring, global governance regimes, and even questions of
human
security. As such,
health can be
explored in a manner that elucidates many critical facets of
global politics,
as well as the intersection between global and national political
terrains. This course
will challenge
students to consider health from a variety of angles and
intellectual
perspectives, encouraging a distinctly political understanding of
health and
problems of political governance (along both global and national
lines). It
begins by examining the extent to which health questions can be
fruitfully
explored through various theoretical and categorical lenses (eg.
class, race,
gender, the ‘biopolitical’).
Following
this, we will devote time to health as an issue of political
economy and the
distinct issues this uncovers in a neoliberal context. The aim will be to
consider the linkages
between the health industry, global trade and restructuring, and
health sector
reform and restructuring in both the advanced industrial and
developing worlds.
Building on this politico-economic understanding of health trends,
the backend
of the course will interrogate emerging issues around the politics
of ‘global
health’ – their meaning, utility, institutional mechanisms and
even
biases.
Course Requirements:
Students are responsible for all required
readings and should come to
seminar fully prepared to discuss and participate. Beyond this, each
student (either alone or in
groups, depending on numbers) will be responsible for a main
presentation,
based on one week’s readings.
The
presentation should deal with conceptual issues implicitly or
explicitly raised
by the articles – they should not be a dry rehearsal of the
articles
themselves. Finally, each student is responsible for a term
paper, weighted at
50%, on a topic of their choice.
Course Breakdown:
Participation: 20%
Term Paper (4-5000 words): 50% (due last day
of class)
Main Presentation (based on readings): 30%
Weekly Schedule:
Week 1: Introduction
Introduction of course, students’
introductions and arrangement of
presentations
Required Reading:
David
G. Whiteis,
“Poverty, policy, and pathogenesis: economic justice and public
health in the
US,” Critical Public Health 10, no.2 (2000), 257-71.
David
Coburn, “Beyond
the income inequality hypothesis:
class, neo-liberalism, and health inequalities,” Social
Science and Medicine
58, no.1 (2004), 41-56.
M. Norman Oliver and C.
Muntaner,
“Researching Health Inequities Among African Americans: The
Imperative to
Understand Social Class,” International Journal of Health
Services 35,
no.3 (2005), 485-98.
Shiloh
Krupar and Nadine
Ehlers, "Biofutures: Race and the governance of health,"
Environment
and Planning D: Society and Space 35, no.2 (2017): 222–240.
José Alcides
Figueiredo
Santos, “Class Divisions and Health Chances in Brazil,” International Journal of Health Services 41, no. 4
(2011): 691–709.
Additional
Reading:
Patrick
Bond and
George Dor, “Uneven Health Outcomes and Neo-Liberalism in
Africa,” International
Journal of Health Services 33, no.3 (2003), 607-30.
Paul
Farmer,
“SARS and Inequality,” The Nation 276, no.20 (2003), 6.
Paul
Farmer,
“Social inequalities and emerging infectious diseases.” Emerging
Infectious
Diseases 2, no.4 (1996), 259-69.
Vincente Navarro, Class Struggle, the
State and Medicine (London:
Martin Robinson, 1978).
Vincente
Navarro,
“The World Health Situation,” International Journal of
Health Services 34,
no.1 (2004), 1-10.
Vincente
Navarro,
“The Politics of Health Inequalities Research in the United
States,” International
Journal of Health Services
34, no.1 (2004): 87–99.
N. Krieger, “Refiguring "race":
Epidemiology, racialized
biology, and biological expressions of race relations,” International
Journal
of Health Services 30, no.1 (2000), 211-6.
John
Stone, “Race
and Healthcare Disparities: Overcoming Vulnerability,” Theoretical
Medicine
and Bioethics 23, no.6 (2002), 499-518.
Nancy
Krieger,
Elizabeth M. Barbeau and Mah-Jabeen Soobader, “Class Matters: US
vs. UK
Measures of Occupational Disparities in Access to Health
Services and Health
Status in the 2000 US National Health Interview Survey,” International
Journal
of Health Services 35, no.2 (2005), 213-36.
Susan
E. Kelly, “'New'
genetics
meets the old underclass: findings from a study of genetic
outreach services in
rural Kentucky,” Critical Public Health 12, no.2
(2002), 169-86.
Mary
Shaw, Daniel
Dorling, David Gordon, George Davey Smith, “Putting time, person
and place
together: the temporal, social and spatial accumulation of
health inequality,” Critical
Public Health 11, no.4 (2001), 289-304.
Carles Muntaner and Marisela B. Gomez,
“Anti-Egalitarianism,
Legitimizing Myths, Racism, and "Neo-McCarthyism" in Social
Epidemiology and Public Health: A Review of Sally Satel s PC,
M.D.,” International
Journal of Health Services 32, no.1 (2002), 1-17.
Carles
Muntaner, Craig Nagoshi,
and Chamberlain Diala, “Racial Ideology and Explanations for
Health
Inequalities Among Middle-Class Whites,” International Journal of
Health Services 31,
no.3 (2001), 659-68.
Eileen O’Keefe, “WHO strategies for Europe: racism
and the Alma-Ata
declaration,” Critical Public Health 1 (1991), 36–41.
Required Reading:
L. Doyal, “Putting gender into health and
globalisation debates: new
perspectives and old challenges,” Third World Quarterly 23,
no.2 (2002),
233-50.
K. Lisa Whittle and Marcia C. Inhorn,
“Rethinking Difference: A
Feminist Reframing of Gender/Race/Class for the Improvement of
Women's Health
Research,” International Journal of Health Services 31,
no.1 (2001),
147-65.
A.
Iyer, G. Sen
& PO Stlin, “The
intersections of
gender and class in health status and health care,” Global Public Health 3, S1 (2008): 13-24.
Olena Hankivsky, “Women’s health,
men’s health, and
gender and health: Implications of intersectionality,” Social Science & Medicine 74 (2012) 1712-20.
Peggy McDonough , Diana Worts , Anne McMunn
, Amanda Sacker, “Social
Change and Women's Health,” International Journal of
Health Services 43,
no. 3 (2013): 499-518.
Additional Reading:
AM Jaggar, “Vulnerable women and
neo-liberal globalization: Debt
burdens undermine women's health in the global South,” Theoretical
Medicine
and Bioethics 23, no.6 (2002), 425-440.
N. Krieger,
“Genders, sexes, and
health: what are the connections - and why does it matter?” International
Journal
of Epidemiology 32, no.4 (2003), 652-7.
L, Doyal, “Sex and gender: The challenges
for epidemiologists,” International
Journal of Health Services 33, no.3 (2003), 569-579.
Elizabeth Ettore, “A critical look at the new
genetics:
conceptualizing the links between reproduction, gender and
bodies,” Critical
Public
Health 12, no. 3 (2002): 237-50
Frank van Balen and Marcia C. Inhorn, “Son
Preference, Sex Selection,
and the ‘New’ New Reproductive Technologies, International
Journal of Health
Services 33, no.2 (2003), 235-52.
Mary
K. Zimmerman and Shirley A.
Hill, “Reforming Gendered Health Care: An Assessment of
Change,” International
Journal of Health Services 30, no.4 (2000), 771-95.
Neil
Renwick,
“The 'nameless fever': The HIV/AIDS pandemic and China's women,”
Third World
Quarterly 23, no.2 (2002), 377-93.
K. Christensen, “Economics without money;
Sex without gender: A
critique of Philipson and Posner's Private choices and public
health: The AIDS
epidemic in an economic perspective,” Feminist Economics 4,
no.2 (1998),
1-24.
Required Reading:
Arnold
S. Relman
and Marcia Angell, “America’s other drug industry distorts
medicine and
politics,” The New Republic, 16 December (2002), 27-42.
Marc-André Gagnon (principal author)
and Joel Lexchin,
“The
Cost of Pushing Pills: A New
Estimate of Pharmaceutical Promotion Expenditures in the
United States”, PLoS Medicine, vol. 5, #1,
January 2008:
pp.1-6.
Rodney
Loeppky, Accumulation and
Constraint: Biomedical
Development and Advanced Industrial Health (Halifax:
Fernwood, 2014), pp.9-50.
Nadine
Ehlers,
“Fat Capital,” Journal of
Cultural Economy 8, no.3 (2015): 260-274.
Jens Seeberg,
“Connecting
Pills
and People: An Ethnography of the Pharmaceutical
Nexus in Odisha,
India,” Medical
Anthropology Journal 26,
no. 2 (2012):
182–200.
Meri
Koivusalo
and Jonathan Tritter, ““Trade Creep” and Implications
of the
Transatlantic Trade and Investment Partnership Agreement for the
United Kingdom
National Health Service,” International
Journal of Health Services 44, no. 1 (2014) 93–111
Additional Reading:
James
S.
McKenzie-Pollock, “The Health Industry,” Journal of Public
Health 54,
no.10 (1964): 1647-52.
Allyson
Pollock,
Price D. ‘Rewriting the regulations: how the World Trade
Organisation could
accelerate privatisation in health care systems’. Lancet 2000;
356:
1995-2000.
Kenneth
C.
Shadlen, “Patents and Pills, Power and Procedure: The
North-South Politics of
Public Health in the WTO,” Studies in Comparative
International Development 39,
no.3 (2004): 76-108.
MG
Bloche, “WTO
deference to national health policy: Toward an interpretive
principle,” Journal
of International Economic Law 5, no.4 (2002), 825-48.
Patricia
Arnold
and Terrie Reeves, “International Trade and Health Policy:
Implications of the
GATS for US Health Care Reform,” Journal
of Business Ethics 63 (2006): 313-32.
James C
Robinson, “The
Commercial
Health Insurance Industry In An Era Of Eroding Employer
Coverage,” Health
Affairs 25, no.6
(2006): 1475-86.
James
Love,
“Pharmaceutical Research and Development and the Patent System,”
International
Journal of Health Services 35, no.2 (2005): 257-63.
Herbert
Gottweis, “The
Governance of Genomics,” Critical Public Health 12,
no.3
(2002): 207-20.
R.G.
Evans and
G.L. Stoddart, "Producing Health, Consuming Health Care" in R.G.
Evans, Morris L. Barer and T.R. Marmor (eds.) Why are Some
People Healthy
and Others Not? The Determinants of Population Health
(New York: Aldine De
Gruyter, 1994), 27-64.
Merrill
Goozner, The
$800 Million Pill: The Truth Behind the Cost of New Drugs
(Berkley:
University of California Press, 2004).
Edward
Yoxen, “Life as a
Productive Force:
Capitalising the Science and Technology of Molecular Biology,”
in Les Levidow
and Bob Young (eds) Science, Technology and the Labour Process. (London:
CSE Books, 1981), 66-122.
Jerome
Kassirer, On
The Take: How Medicine’s Complicity with Big Business Can
Endanger Your Health
(Oxford, Oxford University Press, 2004).
Vincente
Navarro,
Medicine Under Capitalism (New York: Neal Watson
Academic Publications,
1976).
Joel
Lexchin, The
Real Pushers: a critical analysis of the Canadian Drug
Industry (Toronto:
New Star Books, 1984).
Andrew
Herxheimer,
“Relationships between the pharmaceutical industry and patients'
organizations,” British Medical Journal 326 (31 May,
2003), 1208-1210.
Linda
Marsa, Prescriptions
for Profits: How the Pharmaceutical Industry Bankrolled the
Unholy Marriage
Between Science and Business (New York: Scribner, 1997).
Robert Marshall, “Autonomy and
Sovereignty in the
Era of Global Restructuring,” Studies in Political Economy 59
(1999),
115-147.
Rodney Loeppky, Encoding Capital:
The Political
Economy of the Human Genome Project (New York: Routledge,
2005).
Caroline
Thomas,
“Trade policy and the politics of access to drugs,” Third World
Quarterly 23, no.2 (2002), 251-64.
Sarah Sexton, “Trading Health Care
Away? GATS,
Public Services and Privatisation,” The Cornerhouse Briefing 23,
July (2001).
DB
Resnick, “Fair
drug prices and the patent system,” Health Care Analysis
12, no.2
(2004), 91-115.
Meri
Koivusalo,
“World Trade Organisation and Trade-Creep in Health and Social
Policies,” Occasional Paper, Globalism and Social Policy
Programme, Helsinki
(1999).
Scott
Sinclair
and Jim Grieshaber-Otto, Facing the Facts: A Guide to the
GATS Debate
(Ottawa: Canadian Centre for Policy Alternatives, 2002).
Peter
Drahos and
John Braithwaite, Information Feudalism: Who Owns the
Knowledge Economy? (New
York: The New Press, 2002).
John
H. Barton,
“TRIPS And The
Global
Pharmaceutical Market,” Health Affairs 23, no.3
(2004), 146-55.
DW Bettcher, D Yach, and GE Guindon,
“Global trade
and health: key linkages and future challenges,” Bulletin of
the World
Health Organization 78, no.4 (2000), 521-34.
Carlos
M. Correa,
Intellectual property rights, the WTO and developing
countries : the TRIPS
agreement and policy options (New York: Zed, 2000).
Carlos
M. Correa,
“Implementing National Public Health in the Framework of the WTO
Agreements,” Journal
of World Trade 34, no.5 (2000), 89-121.
Susan
Sell,
“Intellectual Property Rights,” in David Held and
Anthony McGrew (eds.)
Governing Globalization (Cambridge: Polity, 2002), 171-88.
Anna Lanoszka, “The Global Politics of
Intellectual Property Rights
and Pharmaceutical Drug Policies in Developing Countries,”
International
Political Science Review 24, no.2 (2003), 181–197
Week 5: Medicalisation?
Required:
Simon
J. Williams
and Michael Calnan, “The Limits of Medicalization?: Modern
Medicine and the Lay
Populace In ‘Late Modernity’,” Social Science and Medicine 42,
no.12
(1996) 1609-1620.
Ray
Moynihan,
Iona Heath and David
Henry, “Selling
sickness: the pharmaceutical industry and disease mongering,” British
Medical
Journal 324, 2002, 886-91.
Leon
R. Kass,
“Ageless Bodies, Happy Souls: Biotechnology and the Pursuit of
Perfection,” The New Atlantis, Spring, 2003, pp.9-28.
Julie
Guthman, “Fatuous
measures:
the artifactual construction of the obesity epidemic,” Critical Public
Health 23, no.
3 (2013): 263-273.
Karen Throsby
and Bethan
Evans, “‘Must I seize every opportunity?’ Complicity,
confrontation and the
problem of researching (anti-) fatness,” Critical
Public Health 23, no. 3 (2013) 331-44.
Carl
Boggs, “The
Medicalized Society,” Critical Sociology 41, no.3 (2015): 517-535.
Additional:
Regina
H. Kenan,
“The At-Risk Health Status and Technology: A Diagnostic
Invitation and the Gift
of Knowing,” Social Science and Medicine 42, no.11
(1996), 1545.
Nikolas
Rose,
“The Politics of Life Itself,” Theory, Culture & Society
18, no.6
(2001): 1-30.
Barbara
Marshall,
“Climacteric Redux? (Re)medicalizing the Male Menopause,” Men and Masculinities 9, 4 (2007): 509-29.
Peter
Conrad,
“Medicalisation and Social Control,” Annual Review of
Sociology 18
(1992): 209-32.
Richard
Eckersley,
“Is modern Western culture a health hazard?” International
Journal of Epidemiology 35 (2005): 252-58.
Roy
Moynihan,
“Who pays for the pizza? Redefining the relationships between
doctors and drug
companies. 1: Entanglement,” British Medical Journal 326
(31 May, 2003),
1189-1192.
Vicki
F. Meyer, “The
Medicalisation of Menopause: Critique and Consequences,” International
Journal of Health Services 31, no.4 (2001), 769-92.
Ray
Moynihan, “The making of a
disease: female sexual dysfunction,” British Medical Journal 326
(4 Jan. 2003), 45-7.
Tim
Brown and Morag Brown, “Off
the couch and on the move: Global public health and the
medicalisation of
nature,” Social Science & Medicine 64
(2007): 1343-54.
Kevin
Harvey, “Medicalisation,
pharmaceutical
promotion and the Internet: a critical multimodal discourse
analysis of hair loss websites,” Social
Semiotics 23, no. 5 (2013): 691-714
Required Reading:
Joanne
Warner, “The
Sociology
of Mental Health: A Brief Review of Major Approaches,” Sociology Compass
3,
no.4 (2009): 630–643.
Julian
Tudor Hart, “Mental
health in a sick society: what are people for?” Socialist Register 2010: Morbid Symptoms (London:
Merlin, 2010): 315-25.
Lawrence C. Pellegrini and Rosa Rodriguez-Monguio, “Unemployment,
Medicaid
provisions, the mental health industry, and suicide,” The
Social
Science Journal
50 (2013):
482–490.
Joseph
Pierce, Deborah
G. Martin, Alexander W. Scherr and Amelia Greiner, “Urban
Politics
and Mental Health: An Agenda for Health Geographic Research,” Annals of the Association of
American
Geographers, 102, no.5 (2012): 1084–1092.
Mark
Cresswell and
Helen Spandler, “Psychopolitics: Peter Sedgwick’s legacy
for the
politics of mental health,” Social
Theory
& Health 7, no. 2, (2009): 129–147.
Alison
Howell, “The Demise
of PTSD: From Governing through Trauma to Governing Resilience,”
Alternatives: Global,
Local, Political
37, no. 39 (2012): 214-226.
Week 7: Food and Health
Required Reading:
Jordan
Kleiman,
“Local Food and the Problem of Public Authority,” Technology and Culture 50, no.2 (2009): 399-417.
Rob
Albritton,
“Between Obesity and Hunger: the Capitalist Food Industry,” Socialist Register 2010:
Morbid Symptoms
(London: Merlin, 2010), 184-197.
Michaela Jackson, Paul Harrison, Boyd Swinburn and Mark Lawrence, “Unhealthy food, integrated marketing
communication
and power: a critical analysis,” Critical
Public Health 24, no.4 (2014): 489-505.
Sanjay
Basu, “The
transitional
dynamics of caloric ecosystems: changes in the food supply
around
the world,” Critical Public Health
25,
no.3 (2015): 248-264.
Jane
Dixon,
et al., “Flexible employment, flexible eating
and health
risks,” Critical
Public Health 24, no.4 (2014): 461-475.
Required Reading:
Michael
Keaney,
“Unhealthy Accumulation: The Globalization of Health Care
Privatization,” Review
of Social Economy 60, no.3 (2002): 331-57.
Göran
Dahlgren, “Why
Public
Health Services? Experiences from profit-driven health care
reform in
Sweden,” International
Journal of Health
Services 44, no. 3, (2014) 507–524.
Susan
Giaimo and
Philip Manow, “Adapting the Welfare State: The Case of Health
Care Reform in
Britain, Germany and the United States,” Comparative
Political Studies,
Vol.32, No.8 (1999), 967-1000.
Robert Evans, “Reform. Re-form and
Reaction in the Canadian Health Care
System,” Health Law
Journal, Special
Edition (2008):
265-86.
John Geyman, “Crisis in U.S. Health Care:
Corporate Power Still Blocks
Reform,” International
Journal of Health
Services 48, no.1 (2018): 5-27.
Additional
Reading:
Birju
Rao and Ida
Hellander, “The Widening U.S. Healthcare Crisis Three Years
After the Passage
of ‘Obamacare’,” International Journal of Health Services 44, no. 2 (2014):
215–232
David
Coburn,
"Health, Health Care and Neo-Liberalism", in Pat Armstrong, Hugh
Armstrong and David Coburn (eds.), Unhealthy Times:
Political Economy
Perspectives on Health and Care in Canada. Toronto:
Oxford, 2001), 45-66.
OECD.
“Overcoming
challenges in health-care reform.” OECD
Economic Surveys – Canada. Paris: OECD. 2010.
Patricia J. Arnold and Terrie C. Reeves, “International
Trade and
Health Policy: Implications of the GATS for US Healthcare
Reform,” Journal
of
Business Ethics 63 (2006): 313–32.
Jacob
Hacker, The
Divided Welfare State (New York: Cambridge University
Press, 2002), 5-70,
179-270, 313-336.
Heather Whiteside, “Canada’s Health Care
‘Crisis’: Accumulation by
Dispossession and the Neoliberal Fix,” Studies
in Political Economy 84 (2009): 79-100.
Vincente
Navarro,
John Schmitt and Javier Astudillo, “Is globalisation undermining
the welfare
state?” Cambridge Journal of Economics 28, no.1 (2004),
133-52.
Ian
Greener, “The
new political economy of the UK NHS,” Critical Public Health
14, no.2
(2004): 239-50.
Hans
Maarse, Privatisation
in European health care : a comparative
analysis
in eight countries (Maarssen: Elsevier
gezondheidszorg, 2004).
Paul
de Vos,
Harrie Dewitte and Patrick Van der Stuyft, “Unhealthy European
Policy,” International
Journal
of Health Services 34, no.2 (2004), 255-69.
Peter
Swenson and
Scott Greer, “Foul Weather Friends: Big Business and Health Care
Reform in the
1990s in Historical Perspective,” Journal of health
Politics, Policy and Law,
Vol.27, No.4 (2002), 605-38.
Susan
Giaimo, Markets
and medicine : the politics of health care reform in Britain,
Germany, and the
United States (Ann Arbour: University of Michigan Press,
2002).
Ellen
Wood, “Class
Compacts, the Welfare State, and
Epochal Shifts,” Monthly Review 49, no.8 (1998), 25-43.
Donald
Bartlett
and James B. Steele, Critical Condition: How Health Care in
America Became
Big Business & Bad Medicine (New York: Random House,
2004).
Wendy
Renade, Markets
and health care : a comparative analysis (New York :
Addison Wesley
Longman, 1998).
Patricia
Kaufert,
“Health Policy and the New Genetics,” Social Science and
Medicine 51
(2000), 823.
Heinz
Redwood, Why
ration health care? : an international study of the United
Kingdom, France,
Germany and public sector health care in the USA (London:
Institute for the
Study of Civil Society, 2000).
Chris
Holden,
“Privatization and Trade in Health Services: A Review of the
Evidence,” International
Journal of Health Services 35, no.4 (2005): 675-89.
Allyson
Pollock, NHS,
plc: The Privatisation of our Health Care (London: Verso,
2004).
Required Reading:
Francesco
Armada,
Charles Muntaner, and Vincente Navarro, “Health and Social
Security Reforms in
Latin America: The Convergence of the World Health Organization,
the World
Bank, and Transnational Corporations,” International Journal
of Health
Services 31, no.4 (2001), 729-68.
David
Woodward,
“The GATS and trade in health services: implications for health
care in
developing countries,” Review of International Political
Economy 12,
no.3 (2005): 511-34.
Mohan
Rao, “‘Health for All'
and neoliberal
globalisation: an Indian rope trick,”
Socialist Register 2010: Morbid Symptoms (London: Merlin,
2010): 262-78.
Julie
Feinsilver, “Cuban Health Politics at Home and Abroad,” Socialist Register
2010: Morbid Symptoms
(London: Merlin,
2010): 216-39.
Vincente Navarro and Wei
Zhang, “Why hasn’t
China’s
high-profile health reform (2003–2012) delivered? An analysis of
its neoliberal
roots,” Critical Social
Policy 34,
no.2 (2014): 175-198.
Additional
Reading:
Dongmei
Liu and
Barbara Darimont, “The health care system of the
People’s Republic
of China: Between privatization and public health care,” International
Social
Security Review 66, no.1 (2013): 97-117.
Michael
Chossudovsky,
“The Globalization of poverty and ill-health: assessing the
IMF-World Bank structural adjustment programme,” in Jeebhay, M.,
Hussey, G.,
Reynolds, L. (eds) The New World Order: A Challenge to
Health for All by the
Year 2000. (Durban: Health Systems Trust, 1997), 53–60.
J.W
Peabody,
“Economic Reform and Health Sector Policy: Lessons from
Structural Adjustment Programs,”
Social Science and Medicine 43, no.5 (1996),
823-35,
Howard
Waitzkin
and Celia Iriat, “How the US Exports Managed Care to Third-World
Countries,” Monthly
Review 52, no.2 (2000).
Meri
Koivusalo,
“The Impact of WTO Agreements on Health and Development
Policies,” Policy Brief
No.3, Globalism and Social Policy Programme, January 2000.
EJ Perez-Stable, “Managed care arrives in
Latin America,” New
England J Med 1999; 340: 1110-12.
L.
Gilson, et
al., “The Potential of Health Sector Non-governmental
Organizations: Policy
Options,” Health Policy and Planning 9, no.1
(1994), 14-24.
Demba
Moussa
Dembele, “The International Monetary Fund and World Bank in
Africa: A
‘Disastrous’ Record,” International Journal
of Health Services 35,
no.2 (2005),
389-98.
M.
Segall,
“District health systems in a neoliberal world: a review of five
key policy
areas,” International Journal of Health Planning and
Management 18,
Supp. 1 (2003), S5-26.
Paul
de Vos, “‘No
One Left Abandoned’: Cuba’s National Health System Since the
1959 Revolution,” International
Journal of Health Services 35, no.1 (2005), 189-207.
Patrick
Bond,
“Globalization, Pharmaceutical Pricing, and South African Health
Policy:
Managing Confrontation with US Firms and Politicians,” International
Journal
of Health Services 29, no.4 (1999), 765-92.
Jerry M Spiegel, Ronald
Labonte and Aleck S
Ostry, “Understanding "Globalization" as a
Determinant of Health
Determinants: A Critical Perspective,” International Journal of
Occupational and
Environmental Health 10,
no.4 (2004), 360-8.
Oscar
Feo and
Carlos Eduardo Siquiera, “An Alternative to the Neoliberal Model
in Health: The
Case of Venezuela,” International Journal of Health Services
34, no.2
(2004), 365-75.
Vincente
Navarro,
“The political economy of the welfare state in developing
countries,” International
Journal of Health Services 29, no.1 (1999), 1-50.
Required Reading:
James
Morone,
“Enemies of the People: The Moral Dimension to Public Health,” Journal
of
Health Politics, Policy and Law 22, no. 4
(1997): 993-1020.
Sanjay
Basu,
“AIDS, empire and public
health behaviouralism,” International Journal of Health
Services 34,
no.1 (2004), 155-67.
Moritz
Hunsmann,
“Pushing ‘Global Health’ out of its Comfort Zone: Lessons from
the
Depoliticization of AIDS Control in Africa,”
Development
and
Change 47, no.4 (2016)): 798–817.
Ronald Labonté,
“Global health
in public policy: finding the right frame?” Critical Public Health
18, no.4 (2008):
467-482.
Shelley
K. White,
“Public health at a crossroads: assessing teaching on
economic
globalization as a social determinant of health,” Critical
Public Health 22, no. 3 (2012): 281–295.
Additional Reading:
David
Fidler, “A
Globalized Theory of Public Health Law,” The Journal of Law,
Medicine and Ethics
30, no.2 (2002), 150-163.
Yach,
Derek and
Bettcher, Douglas. “The Globalization of Public Health, I:
Threats and
Opportunities.” American Journal of Public Health 88,
no.5 (1998),
735-737.
Yach,
Derek and
Bettcher, Douglas. “The Globalization of Public Health, II: The
Convergence of
Self-Interest and Altruism.” American Journal of Public
Health 88, no.5
(1998), 738-743.
Giovanni Berlingeur, “Globalization and
Global
Health,” International Journal of Health Services 29, no.3
(1999),
579-95.
Carles Muntaner, John Lynch, and George
Davey Smith,
“Social Capital, Disorganized Communities, and the Third Way:
Understanding the
Retreat from Structural Inequalities in Epidemiology and Public
Health,” International
Journal of Health Services 31, no.2 (2001), 213-37.
Eileen
O’Keefe,
“Equity, democracy and globalization,” Critical Public
Health 10, no.2
(2000), pp.167-177.
Kelley
Lee, “The
impact of globalization on public health: implications for the
UK Faculty of
Public Health Medicine,” Journal of Public Health Medicine 22, no.3 (2000), 253-262.
Moises
Naim: “The
Global Battle for Public Health,” Foreign Policy, Vol.128
(2002), 24-36
Tea
Collins,
“Globalization, global health, and access to healthcare,” International
Journal
of Health Planning Management, Vol.18 (2003).
Ilona
Kickbusch,
“Influence and Opportunity: Reflections on the US role in Global
Public
Health,” Health Affairs 21, no.6 (2002), 131-41.
A
J McMichae
and R Beaglehole, “The
changing
global context of public health,” Lancet 356 (2000),
495-
Tim
Brown and
Morag Bell, “Off the couch and on the move: Global public health
and the
medicalisation of nature,” Social Science and Medicine
64 (2007):
1343-54.
Tony
Evans, “A
human right to health?” Third World Quarterly 23, no.2
(2002), 197-215.
Richard
Horton,
“The Health of Peoples: Predicaments Facing a Reasoned Utopia,”
International
Journal of Health Services 33, no.3 (2003), 543-63.
Stefan
Elbe,
“HIV/AIDS and the Changing Landscape of War in Africa,” International
Security
27, no.2 (2002), 159-77.
Fantu
Cheru,
“Debt, adjustment and the politics of effective response to
HIV/AIDS in
Africa,” Third World Quarterly 23, no.2 (2002), 299-312.
Susan
Hunter, Who
Cares: AIDS in Africa (Basingstoke, Palgrave, 2003).
Fairchild,
Amy L.,
and Tynan, Eileen A. “Policies of Containment: Immigration in
the Era of AIDS.”
American Journal of Public Health 84, no.12 (1994),
2011-2022.
Foege,
William H.
“In Search of a National Agenda for International Health
Problems.” American
Journal of Tropical
Medicine and
Hygiene 42, no.4 (1990), 293-97
SH
Nelson, “The
West’s moral obligation to assist developing nations in the
fight against
HIV/AIDS,” Health Care Analysis 10, no.1 (2002), 87-108.
Mark
Schlesinger,
“Paradigms Lost: The Persisting Search for Community in US
Health
Policy,” Journal of Health Politics, Policy and Law 22,
no.4 (1997):
937-91.
Bruce
Spitz,
“Community Control in a World of Regional Delivery Systems,” Journal
of
Health Politics, Policy and Law 22, no. 4 (1997):
1021-50.
Benjamin
Mason
Meier, “Employing Health Rights for Global Justice: The Promise
of Public
Health in Response to the Insalubrious Ramifications of
Globalization,” Cornell
International Law Journal 39, no.3 (2006): 711-78.
Week 11: (Global) Public Health – What is
to be done? Who is responsible?
Steven
Friedman
and Shauna Mottiar, “A Rewarding Engagement? The Treatment
Action Campaign and
the Politics of HIV/AIDS,” Politics and Society 33, no.4
(2005): 511-65.
Sanjay
Basu, “Building a
comprehensive public health
movement: learning from HIV/AIDS mobilizations,” Socialist Register 2010: Morbid Symptoms (London:
Merlin, 2010):
295-314.
Meri
Koivusalu,
“The Shaping of Global Health Policy,” Socialist
Register 2010: Morbid Symptoms (London: Merlin, 2010),
279-94.
Colin
McInnes, et
al., “Framing global health: The governance challenge,” Global Public Health
7,
no. S2 (2012): S83-S94.
Devin
K.
Joshi and Bin Yu, “Political Determinants of Health
Investment in
China and India,” Asian
Politics
& Policy 6, no.1 (2014): 59–82.
Additional
Reading:
Mark Heywood, “Drug access, patents and
global
health: 'chaffed and waxed sufficient’,” Third World Quarterly
23, no.2
(2002), 217-31.
Carles
Muntaner,
John Lynch, George Davey Smith,
“Social
capital
and the third way in public health,”
Critical Public Health
10, no.2 (2000): 107-24.
Beatrix
Freeman,
“Health Care Reform and Social Movements in the United States,”
American
Journal of Public Health 93, no.1 (2003) 75-86.
Scott
A Fritzen, “Legacies
of
primary health care in an age of health sector reform: Vietnam's
commune
clinics in transition,” Social Science & Medicine
64, no.8 (2007):
1611-23.
Peris Jones, “‘‘A Test of Governance’’:
rights-based
struggles and the politics of HIV/AIDS policy in South Africa,”
Political Geography
24, no.4 (2005)
419–47.
Shannon
Mitchell
and Stephen Shortell, “The Governance and Management of
Effective Community
Health Partnerships: A Typology for Research, Policy and
Practice,” The
Milbank Quarterly 78, no.2 (2000): 241-89.
Ilona
Kickbusch,
“The development of international health policies—accountability
intact?” Social
Science and Medicine 51 (2000): 979-989.
Krista
Johnson,
“Globalization, Social Policy and the State: An Analysis of
HIV/AIDS in South
Africa,” New Political Science 27, no.3 (2005): 309-29.
Kelley Lee, Sue Collinson, Gill Walt,
Lucy Gilson,
“Who should be doing what in international health: a confusion of
mandates in the
United Nations?” British Medical Journal 312 (1996),
302-7.
Nana
K Poku, “The
Global AIDS Fund: context and opportunity,” Third World
Quarterly 23,
no.2 (2002), 283-98.
Alan
Whiteside
and Alex de Waal, “ ‘That’s Resources You See!’: Political
Economy, Ethics and
the HIV/AIDS Epidemic,” New Political Economy 9, no.4
(2004), 581-94.
Nana
K. Poku,
“Global Pandemics: HIV/AIDS,” in David Held and Anthony McGrew
(eds.) Governing
Globalization (Cambridge:Polity, 2002), 111-26
Nana
K Poku and
Alan Whiteside, “Global health and the politics of governance:
an
introduction,” Third World Quarterly 23, no.2 (2002),
191-5.
Kelly
Lee and
Richard Dodgson, “Globalization and Cholera: Implications for
Global
Governance,” Global Governance, Vol.6, No.2 (2000),
213-36.
Debabar
Banerji,
“Reinventing Mass Communication: A World Health Organization
Tool For
Behavioural Change to Control Disease,” International
Journal of
Health Services 34, no.1 (2004), 15-24.
Debabar
Banerji,
“Report on the WHO Commission on Macroeconomics and Health,” International
Journal of Health Services 32, no.4 (2002), 733-54.
Required Reading:
Melinda
Cooper,
“Pre-empting Emergence: The Biological Turn in the War on
Terror,” Theory,
Culture & Society 23, no.4 (2006): 113-35.
Alexander
Kelle,
“Securitization of International Public Health:
Implications for Global
Health Governance and the Biological Weapons Prohibition
Regime,” Global
Governance
13 (2007): 217– 235.
Tim
Brown, “
‘Vulnerability is Universal’: considering the place of security
and
vulnerability within contemporary global health discourse,” Social Science &
Medicine 72 (2011):
319-26.
Jed Horner, James G. Wood and Angela Kelly, “Public health in/as ‘national security’: tuberculosis and
the
contemporary regime of border control in Australia,” Critical Public Health, 23, no.4 (2013): 418-431.
Melissa Curley and
Jonathan
Herington, “The securitisation of avian influenza: international
discourses and
domestic politics in Asia,” Review of International
Studies 37 (2011): 141–166.
Additional Reading:
Laurie
Garrett,
“The Nightmare of Bioterrorism,” Foreign Affairs 80,
no.1 (2001), 76-89.
David
Fidler,
“Public Health and National Security in the Global Age:
Infectious Diseases,
Bioterrorism and Realpolitik,” The George Washington
International Law
Review 35, no.4 (2003), 787-856. **Read what you can of
this article.
EM Prescott, “SARS: A warning,” Survival
45, no.3 (2003) 207-+
Susan
Wright,
“Varieties of Secrets and Secret Varieties: The Case of
Biotechnology,” Politics
and the Life Sciences 19, no.1 (2000).
Colin
McInnes and
Kelley Lee, “Health, security and foreign policy,” Review of
International
Studies 32 (2006): 5-23.
Stefan
Elbe,
“AIDS, Security, Biopolitics,” International Relations, Special
Issue on
Health, (2005)
Stefan Elbe, ‘Should HIV/AIDS be
Securitized? The Ethical Dilemmas of
Linking HIV/AIDS and Security,” International Studies
Quarterly,(2006).
Rodney
Loeppky,
“Biomania and US Foreign Policy,” Millennium:
Journal of International Studies 34, no.1 (2005): 85-113.
Raymond
A.
Zilinskas, “Rethinking Bioterrorism,” Current History 100
(2001),
438-442.
Andrew T. Price-Smith, The Health of
Nations: Infectious Disease,
Environmental Change, and Their Effects on National Security
and Development (Camb.,
Mass.: MIT Press, 2001).
Christopher
F.
Chyba, “Toward Biological Security,” Foreign Affairs 81,
no.3 (2002),
93-106.
Robert
L.
Paarlberg, “Knowledge as Power: Science, Military Dominance, and
U.S.
Security,” International Security 29, no.1 (2004),
122-51.
Gregory
Koblentz,
“Pathogens as Weapons: The International Security Implications
of Biological
Warfare,” International Security 28, no.3 (2003),
84-122.
Heinecken,
Lindy, “Living in Terror: The Looming Security Threat to
Southern Africa,” African
Security Review 10, no.4 (2001), 7-17.
Milton
Leitenberg,
“Biological Weapons and Bioterrorism in the first years of the
twenty-first century,” Politics and the Life Sciences
21, no.2 (2002),
3-27.
Peter
Singer,
‘AIDS and International Security’, Survival, 44, no.1
(2002), 145-58.
Bill
Frist,
“Public Health and National Security: the critical role of
increased federal
support,” Health Affairs 21, no.6 (2002), 117+